Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations.
Dusser D, Montani D, Chanez P, de Blic J, Delacourt C, Deschildre A, Devillier P, Didier A, Leroyer C, Marguet C, Martinat Y, Piquet J, Raherison C, Serrier P, Tillie-Leblond I, Tonnel AB, Tunon de Lara M, Humbert M. Dusser D, et al. Among authors: leroyer c. Allergy. 2007 Jun;62(6):591-604. doi: 10.1111/j.1398-9995.2007.01394.x. Allergy. 2007. PMID: 17508962 Review.
[Characteristics of mild asthma: descriptive epidemiology and nature of bronchial inflammation. Position of the Mild Asthma Working Group].
Chanez P, de Blic J, Delacourt C, Deschildre A, Devillier P, Didier A, Dusser D, Humbert M, Leroyer C, Marguet C, Martinat Y, Piquet J, Raherison C, Serrier P, Tillie-Leblond I, Tonnel AB, Tunon de Lara M; French Mild Asthma Working Group. Chanez P, et al. Among authors: leroyer c. Rev Mal Respir. 2006 Sep;23(4 Suppl):13S17-28. Rev Mal Respir. 2006. PMID: 17057629 Review. French.
[Characteristics of mild asthma: clinical signs and medication use. Position statement of the Mild Asthma Working Group (174)].
Chanez P, de Blic J, Delacourt C, Deschildre A, Devillier P, Didier A, Dusser D, Humbert M, Leroyer C, Marguet C, Martinat Y, Piquet J, Raherison C, Serrier P, Tillie-Leblond I, Tonnel AB, Tunon de Lara M; Groupe de Travail sur l'Asthme Léger. Chanez P, et al. Among authors: leroyer c. Rev Mal Respir. 2006 Dec;23(6):607-18. doi: 10.1016/s0761-8425(06)72076-9. Rev Mal Respir. 2006. PMID: 17202966 Review. French.
[The role of clinical examination in allergic asthma?].
Wallaert B, Kouzan S, Leroyer C, Delacourt C, Roguedas AB. Wallaert B, et al. Among authors: leroyer c. Rev Mal Respir. 2007 Oct;24(8 Pt 3):7S34-40. Rev Mal Respir. 2007. PMID: 18033201 French. No abstract available.
Fenfluramine-like cardiovascular side-effects of benfluorex.
Boutet K, Frachon I, Jobic Y, Gut-Gobert C, Leroyer C, Carlhant-Kowalski D, Sitbon O, Simonneau G, Humbert M. Boutet K, et al. Among authors: leroyer c. Eur Respir J. 2009 Mar;33(3):684-8. doi: 10.1183/09031936.00086308. Eur Respir J. 2009. PMID: 19251806 Free article.
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
Humbert M, de Blay F, Garcia G, Prud'homme A, Leroyer C, Magnan A, Tunon-de-Lara JM, Pison C, Aubier M, Charpin D, Vachier I, Purohit A, Gineste P, Bader T, Moussy A, Hermine O, Chanez P. Humbert M, et al. Among authors: leroyer c. Allergy. 2009 Aug;64(8):1194-201. doi: 10.1111/j.1398-9995.2009.02122.x. Allergy. 2009. PMID: 19614621 Clinical Trial.
Allergic bronchopulmonary aspergillosis and omalizumab.
Tillie-Leblond I, Germaud P, Leroyer C, Tétu L, Girard F, Devouassoux G, Grignet JP, Prudhomme A, Dusser D, Wallaert B. Tillie-Leblond I, et al. Among authors: leroyer c. Allergy. 2011 Sep;66(9):1254-6. doi: 10.1111/j.1398-9995.2011.02599.x. Epub 2011 Apr 26. Allergy. 2011. PMID: 21517902 No abstract available.
[Seasonality in asthma: Impact and treatments].
Guilleminault L, Just J, Humbert M, Leroyer C, Epaud R. Guilleminault L, et al. Among authors: leroyer c. Presse Med. 2016 Nov;45(11):1005-1018. doi: 10.1016/j.lpm.2016.01.019. Epub 2016 Mar 30. Presse Med. 2016. PMID: 27039335 Review. French.
178 results